Robust cost efficacy of a novel, validated screening test at 12–20 Weeks gestation for the prediction of preterm birth (PTB) at or before 32 Weeks in singletons
- Resource Type
- Article
- Source
- In
Gynecology and Obstetrics Clinical Medicine September 2021 1(3):107-111 - Subject
- Language
- ISSN
- 2667-1646